xMD Diagnostics

xMD Diagnostics is a private molecular diagnostics tools company developing laboratory instruments and consumables for research, biopharmaceutical, and CLIA clinical laboratory markets. Its core technology, expression microdissection (xMD), is designed to isolate, procure, and enrich specific cells or regions of interest from tissue and specimen samples to improve downstream molecular testing workflows. The company positions its products as a more automated, precise, and cost-effective alternative to manual tissue selection methods such as razor scraping and to certain existing microdissection workflows. xMD's applications span pathology, oncology, genomics, proteomics, PCR, and next-generation sequencing, with an emphasis on improving diagnostic accuracy and efficiency in cancer and other serious genetic diseases. The business appears to be a tools/platform company rather than a therapeutics developer, with value centered on sample preparation, cell enrichment, and precision diagnostics enablement.